Article Details
Retrieved on: 2022-07-22 15:32:36
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The research was funded by Roche, which markets Evrysdi. Evrysdi is an oral therapy that works to boost production of the SMN gene whose deficit ...
Article found on: smanewstoday.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here